| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +74 | +6.3% | $0.000000 | 1,250 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $11,806 | -35 | -2.8% | $337.32 | 1,215 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +42 | +3.5% | $0.000000 | 1,257 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $6,746 | -20 | -1.6% | $337.32 | 1,237 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +31 | +2.5% | $0.000000 | 1,268 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $5,060 | -15 | -1.2% | $337.32 | 1,253 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +44 | +3.5% | $0.000000 | 1,297 | 02 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $7,084 | -21 | -1.6% | $337.32 | 1,276 | 02 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +56 | +4.4% | $0.000000 | 1,332 | 03 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $9,026 | -27 | -2% | $334.31 | 1,305 | 03 Sep 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -74 | -25% | $0.000000 | 224 | 01 Sep 2024 | Bio-Rad A Common Stock | 74 | $0.000000 | Direct | F2, F3 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -42 | -33% | $0.000000 | 84 | 01 Sep 2024 | Bio-Rad A Common Stock | 42 | $0.000000 | Direct | F2, F4 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -31 | -50% | $0.000000 | 31 | 01 Sep 2024 | Bio-Rad A Common Stock | 31 | $0.000000 | Direct | F2, F5 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -44 | -100% | $0.000000 | 0 | 02 Sep 2024 | Bio-Rad A Common Stock | 44 | $0.000000 | Direct | F2, F6 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -56 | -100% | $0.000000 | 0 | 03 Sep 2024 | Bio-Rad A Common Stock | 56 | $0.000000 | Direct | F2, F7 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F4 | On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |